Novel 660 300 mg (Trimethobenzamide Hydrochloride 300 mg)
Pill with imprint Novel 660 300 mg is Purple, Capsule-shape and has been identified as Trimethobenzamide Hydrochloride 300 mg. It is supplied by Gavis Pharmaceuticals.
Trimethobenzamide is used in the treatment of nausea/vomiting and belongs to the drug class anticholinergic antiemetics. FDA has not classified the drug for risk during pregnancy. Trimethobenzamide 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Novel 660 300 mg
Trimethobenzamide Hydrochloride
- Imprint
- Novel 660 300 mg
- Strength
- 300 mg
- Color
- Purple
- Size
- 14.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Anticholinergic antiemetics
- Pregnancy Category
- N - Not classified
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Gavis Pharmaceuticals
- National Drug Code (NDC)
- 43386-0660
- Inactive Ingredients
-
lactose monohydrate, magnesium stearate, corn starch, D&C Red No. 28, gelatin, FD&C Blue No. 1, FD&C Red No. 40, titanium dioxide, soya lecithin, water, shellac, ethylene glycol monoethyl ether
Note: Inactive ingredients may vary.
More about trimethobenzamide
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 8 Reviews
- Drug class: anticholinergic antiemetics
- FDA Alerts (1)
Consumer resources
- Trimethobenzamide oral/injection
- Trimethobenzamide Capsules
- Trimethobenzamide Injection Solution
- Trimethobenzamide (Advanced Reading)
- Trimethobenzamide Intramuscular (Advanced Reading)
Other brands: Tigan, Benzacot, Ticon
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
